Lupkynis

Active Ingredient(s): Voclosporin
FDA Approved: * January 22, 2021
Pharm Company: * AURINIA
Category: Immunosuppressive

Voclosporin, sold under the brand name Lupkynis, is a calcineurin inhibitor used as an immunosuppressant medication.[2] It was approved by the U.S. Food and Drug Administration (FDA) for the treatment of lupus nephritis (LN) in January 2021.[3][4][5] It is an analog of ciclosporin that has enhanced action against calcineurin and greater metabolic stability.[6] Voclosporin was discovered by Robert T. Foster and hi... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Lupkynis 7.9 mg Oral Capsule

NDC: 75626-001

Labeler:

Aurinia Pharma U.S., Inc.